Table 2: Standard multidrug therapy regimens for paucibacillary and multibacillary leprosy in adults and children (WHO).
|
Clinical presentations |
Population
|
Agents |
Dosing regimen |
Treatment duration |
|
Paucibacillary leprosy |
Adults
Children |
Rifampicin Dapsone
Rifampicin Dapsone |
600 mg/month 100 mg/day
450 mg/month 50 mg/day |
6 months
6 months |
|
Multibacillary leprosy |
Adults
Children |
Rifampicin Clofazimine
Dapsone
Rifampicin Clofazimine
Dapsone
|
600 mg/month 300 mg/month and 50 mg/day 100 mg/day
450 mg/month 150 mg/month and 50 mg/day
50 mg/day |
12 months
12 months
|